Adrian R. Krainer - Jun 8, 2021 Form 4 Insider Report for Stoke Therapeutics, Inc. (STOK)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	STOK	Director Stock Option (Right to Buy)	Award	$0	+11.7K		$0.00	11.7K	Jun 8, 2021	Common Stock	11.7K	$40.37	Direct	F1

Showing 1 to 1 of 1 entries

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The option shall fully vest on June 8, 2022 or, if earlier, the next annual meeting of the issuer's stockholders, subject to the reporting holder's continued service on such vesting date.